Russell Bialecki - Concepedia

Author

Russell Bialecki

Also Known As

, R A Bialecki, R Bialecki, R. A. Bialecki, R. Bialecki, R.A. Bialecki, RUSSELL A. BIALECKI, Russell A Bialecki, Russell A. Bialecki, Russell Bialecki

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United States)AstraZeneca (United Kingdom)Wilmington University Brigham and Women's Hospital Drexel University

About

Russell Bialecki is an author at AstraZeneca (United States) specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	868
2	Engineering	1	1	40
3	Health Sciences	1	1	52
4	Natural Sciences	1	1	51
5	Public Health	1	1	14

Russell Bialecki

Publications

Citations

H-Index

Page 1

	Year	Citations
A framework to assess the translation of safety pharmacology data to humans Jean‐Pierre Valentin, Russell Bialecki, Lorna Ewart, Journal of Pharmacological and Toxicological Methods Drug SafetyTranslational MedicinePreclinical Drug EvaluationPatient SafetyPharmacology	2009	94
Excess membrane cholesterol alters calcium channels in arterial smooth muscle Russell Bialecki, Thomas N. Tulenko American Journal of Physiology-Cell Physiology Tension DevelopmentMolecular PhysiologyBiochemistryCholesterol EnrichmentAtherosclerosis	1989	87
KCa channel antagonists reduce NO donor-mediated relaxation of vascular and tracheal smooth muscle Russell Bialecki, C. Stinson-Fisher American Journal of Physiology-Lung Cellular and Molecular Physiology Muscle FunctionKca ChannelTracheal Smooth MuscleNitric OxideCellular Physiology	1995	84
Stretch increases inositol trisphosphate and inositol tetrakisphosphate in cultured pulmonary vascular smooth muscle cells Thomas J. Kulik, Russell Bialecki, Wilson S. Colucci, Biochemical and Biophysical Research Communications Pulmonary Arterial HypertensionMuscle FunctionMolecular PhysiologyPulmonary CirculationPhysiology	1991	57
Cholesterol increases the L-type voltage-sensitive calcium channel current in arterial smooth muscle cells. Luyi Sen, Russell Bialecki, Earl Smith, Circulation Research Lipid MovementCardiovascular FunctionCellular PhysiologyMuscle PhysiologyMembrane Free Cholesterol	1992	52
Design, Synthesis, and SAR of Tachykinin Antagonists: Modulation of Balance in NK<sub>1</sub>/NK<sub>2</sub> Receptor Antagonist Activity Jeffrey S. Albert, David Aharony, Donald W. Andisik, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryAntagonist Zd6021Tachykinin AntagonistsBiochemistry	2002	51
A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissions Lorna Ewart, Aileen Milne, Debbie Adkins, Journal of Pharmacological and Toxicological Methods Drug SafetyB Regulatory SubmissionsPreclinical Drug EvaluationPredictive ToxicologyMedicine	2013	50
Cholesterol-induced changes in rabbit arterial smooth muscle sensitivity to adrenergic stimulation R. Broderick, Russell Bialecki, Thomas N. Tulenko American Journal of Physiology-Heart and Circulatory Physiology HypertensionCardiovascular FunctionAdrenal GlandPhysiological ResearchCholesterol Content	1989	49
The mitochondrial fission protein Drp1 in liver is required to mitigate NASH and prevents the activation of the mitochondrial ISR Janos Steffen, Jennifer Ngo, Sheng-Ping Wang, Molecular Metabolism	2022	46
The discovery of non-basic atrial natriuretic peptide clearance receptor antagonists. part 1 Chris A. Veale, Vernon Alford, David Aharony, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyPart 1Cardiovascular DiseaseMedicinePhysiology	2000	44

Page 1